Search research articles
Contact Us
Filters
Showing results (51-60 of 65) with videos related to
Page
of 7
Sort By:
Internal Medicine (Tokyo, Japan)
|
January 1, 1994
Development of pseudolymphoma of liver following interferon-alpha therapy for chronic hepatitis B
T Ohtsu, Y Sasaki, H Tanizaki, et al.
Japanese Journal of Cancer Research : Gann
|
January 1, 1995
A limited sampling model for estimating pharmacokinetics of CPT-11 and its metabolite SN-38
Y Sasaki, S Mizuno, H Fujii, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
April 1, 1988
[Clinical significance of serum levels of SCC antigen in patients with esophageal squamous cell carcinoma]
K Ikeda, M Terashima, K Ishida, et al.
British Journal of Cancer
|
July 15, 2010
Secretion of intelectin-1 from malignant pleural mesothelioma into pleural effusion
S Tsuji, Y Tsuura, T Morohoshi, et al.
Japanese Journal of Clinical Oncology
|
August 15, 1998
Successful treatment with nedaplatin in patients with ovarian cancer that recurred after platinum-containing chemotherapy: report of two cases
K Itoh, T Yamashita, H Wakita, et al.
Japanese Journal of Clinical Oncology
|
April 17, 1998
Determination of cytosol c-erbB-2 protein in breast cancer by sandwich enzyme immunoassay
S Imoto, H Ohkura, K Sugano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 8, 1998
Feasibility and pharmacokinetic study of a chimeric anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab) in relapsed B-cell lymphoma. The IDEC-C2B8 Study Group
K Tobinai, Y Kobayashi, M Narabayashi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 2000
Study of dose escalation and sequence switching of administration of the combination of docetaxel and doxorubicin in advanced breast cancer
K Itoh, Y Sasaki, H Fujii, et al.
Japanese Journal of Cancer Research : Gann
|
February 27, 2001
Phase I study of intravenous PSC-833 and doxorubicin: reversal of multidrug resistance
H Minami, T Ohtsu, H Fujii, et al.
International Journal of Hematology
|
May 25, 2001
Re-treatment of relapsed indolent B-cell lymphoma with rituximab
T Igarashi, T Ohtsu, H Fujii, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 65) with videos related to
Sort By:
Page
of 7
Internal Medicine (Tokyo, Japan)
|
January 1, 1994
Development of pseudolymphoma of liver following interferon-alpha therapy for chronic hepatitis B
T Ohtsu, Y Sasaki, H Tanizaki, et al.
Japanese Journal of Cancer Research : Gann
|
January 1, 1995
A limited sampling model for estimating pharmacokinetics of CPT-11 and its metabolite SN-38
Y Sasaki, S Mizuno, H Fujii, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
April 1, 1988
[Clinical significance of serum levels of SCC antigen in patients with esophageal squamous cell carcinoma]
K Ikeda, M Terashima, K Ishida, et al.
British Journal of Cancer
|
July 15, 2010
Secretion of intelectin-1 from malignant pleural mesothelioma into pleural effusion
S Tsuji, Y Tsuura, T Morohoshi, et al.
Japanese Journal of Clinical Oncology
|
August 15, 1998
Successful treatment with nedaplatin in patients with ovarian cancer that recurred after platinum-containing chemotherapy: report of two cases
K Itoh, T Yamashita, H Wakita, et al.
Japanese Journal of Clinical Oncology
|
April 17, 1998
Determination of cytosol c-erbB-2 protein in breast cancer by sandwich enzyme immunoassay
S Imoto, H Ohkura, K Sugano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 8, 1998
Feasibility and pharmacokinetic study of a chimeric anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab) in relapsed B-cell lymphoma. The IDEC-C2B8 Study Group
K Tobinai, Y Kobayashi, M Narabayashi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 2000
Study of dose escalation and sequence switching of administration of the combination of docetaxel and doxorubicin in advanced breast cancer
K Itoh, Y Sasaki, H Fujii, et al.
Japanese Journal of Cancer Research : Gann
|
February 27, 2001
Phase I study of intravenous PSC-833 and doxorubicin: reversal of multidrug resistance
H Minami, T Ohtsu, H Fujii, et al.
International Journal of Hematology
|
May 25, 2001
Re-treatment of relapsed indolent B-cell lymphoma with rituximab
T Igarashi, T Ohtsu, H Fujii, et al.
Page
of 7